The short answer
A specific SAMe interaction with asenapine is not established. Discuss the supplement with your mental-health prescriber before adding it.
What this answer covers
Oral S-adenosylmethionine supplement; concentrated mood product distinct from ordinary dietary nutrients.
- Supplement or preparation
- S-Adenosylmethionine
- Medication ingredient
- asenapine
Mood history matters
NCCIH cautions that SAMe may worsen mania in people with bipolar disorder. This is a supplement concern, not proof that asenapine causes a new interaction.
The human trial used other medicines
A small SAMe study added it to serotonin-reuptake inhibitors. Its results do not establish the safety or benefit of adding it to asenapine.
Do not convert mechanism into a diagnosis
General advice about serotonin-increasing products does not establish serotonin syndrome with this exact combination. Review all antidepressants and supplements as well as the prescribed antipsychotic.
Keep treatment supervised
Bring the product and your reason for taking it to the prescriber. Do not use SAMe to replace or offset asenapine, and report substantial changes in sleep, energy or behavior.
Evidence and practical considerations
Side effects & toxicity
Exact-pair side-effect claim remains insufficient; psychiatric history and other medicines justify individual review.
- Exact scope
- Oral S-adenosylmethionine supplement; concentrated mood product distinct from ordinary dietary nutrients. with Exact asenapine maleate sublingual tablets or asenapine transdermal system, distinguished by route. Exact RxNorm IN784649; SAPHRIS maleate sublingual tablet and SECUADO asenapine transdermal system distinguished. Do not assign swallowed-tablet or sublingual food/drink instructions to the patch.
- Medication form and route
- sublingual; transdermal
- Timing or duration
- Source-specific single-dose, repeated-dose and observational exposures distinguished.
What remains uncertain
- No exact combination trial or measured event rate. General serotonin advice cannot be assigned automatically to an antipsychotic.
Factors that may matter: preparation and plant part; clinical indication; dose; other medicines; baseline alertness.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed asenapine.
Somnolence, orthostatic and QT precautions. UGT1A4 and CYP1A2 major metabolism; no dose adjustment advised with CYP3A4 inducers based on PK studies. Do not eat or drink for ten minutes after a sublingual dose.
How this applies: Exact asenapine maleate sublingual route; patch instructions require the separate SECUADO label.
No supplement-specific event rate, universal timing rule or untested route/preparation equivalence.
Source 2: official supplement guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: People considering SAMe.
Possible interaction with serotonin-increasing medicines and supplements; bipolar disorder and limited long-term safety warrant review.
How this applies: Supplement-only concern, not a serotonin-syndrome warning in the antipsychotic label.
General supplement psychiatric precautions, not an exact asenapine interaction or incidence.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 73 serotonin reuptake inhibitor nonresponders with major depression.
Response and remission favored SAMe; discontinuation due to adverse events was not significantly different.
How this applies: Other-medicine clinical context only.
Serotonin-reuptake-inhibitor augmentation trial; no asenapine coexposure established.
Source 4: official product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Adults with schizophrenia prescribed asenapine patches.
Somnolence, cognitive/motor, orthostatic and QT precautions; clinical interaction data include studies of sublingual asenapine.
How this applies: Exact ingredient in a distinct transdermal formulation; route bridge kept explicit.
No exact supplement interaction study; sublingual food/drink interval cannot be assigned to the patch.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Research summary published | |
| Article prepared | |
| Current exact available claims adjudicated using original captures and explicit identity and comparator limits. |
Article revision: 90f3c6b3719d2f50
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.